Washington, D.C.―Starting September 1 of this year, companies seeking to certify personal care products under the Natural Products Association’s (NPA) Natural Standard for Personal Care Products program must now be sure their products only contain all-natural fragrances. Unlike what is the case now, organizations must have documentation their fragrances’ composition; and they must be made with all-natural processes. Although companies with products that have been previously certified are not required to immediately make these changes, they should be prepared to do so once their recertification time comes.
Washington, D.C.—In June, WholeFoods told readers about pending legislation that sought to expand the Federal Trade Commission (FTC)’s authority so that the agency could devise and implement its own rules. Now, on June 25, Congress has decided not to include this language in its Wall Street Reform bill (S. 3217).
Monheim, Germany—In a much anticipated move, raw materials giant Cognis Holding GmbH, based here, agreed to sell all its shares to BASF. The transaction, valued at nearly $3.8 billion (3.5 billion euros), will close in November of this year. Cognis made in $3.1 billion (2.6 billion euros) sales in 2009.
This year, as we celebrate New Seasons Market’s accomplishments, we are also celebrating the 20th anniversary of honoring the industry’s most notable retailers. Congratulations to all past winners of the Retailer of the Year Award. We’d love to hear from past winners and retailers nationwide—tell us what’s on your mind! Share your thoughts and see how these businesses have fared over the years.
Washington, D.C.—The Environmental Working Group (EWG) released the 4th edition of its annual Sunscreen Guide. In all, the guide assessed about 1,400 products with SPF, including beach and sports lotions, sprays and creams, moisturizers, make-up and lip balms.
WholeFoods Science Editor, Richard A. Passwater, Ph.D. reports that the District Court in Washington, D.C., has ordered the U.S. Food and Drug Administration (FDA) to take corrective action to restore first amendment protection and allow reasonable and truthful health claims.